Jarda T. Wroblewski
Affiliations: | Georgetown |
Area:
Neuropharmacology, glutamate receptorsWebsite:
http://pharmacology.georgetown.edu/faculty/facwrobl.htmlGoogle:
"Jarda Wroblewski"Mean distance: 15.07 (cluster 6) | S | N | B | C | P |
Parents
Sign in to add mentorJerzy W. Lazarewicz | grad student | Polish Academy of Sciences | |
Erminio Costa | research scientist | Georgetown |
Children
Sign in to add traineeAndrew C. Emery | grad student | 2011 | Georgetown |
Guy Rodrigue R. Takoudjou | grad student | 2012 | Georgetown |
Hannah A. Hathaway | grad student | 2014 | Georgetown |
John O Diraddo | grad student | 2009-2014 | Georgetown |
Tara Gelb | grad student | 2010-2015 | Georgetown |
Carrie Bowman-Dalley | grad student | 2011-2017 | Georgetown |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Bowman Dalley C, Wroblewska B, Wolfe BB, et al. (2018) The Role of Metabotropic Glutamate Receptor 1 Dependent Signaling in Glioma Viability. The Journal of Pharmacology and Experimental Therapeutics |
Gelb T, Pshenichkin S, Hathaway HA, et al. (2015) Atypical signaling of metabotropic glutamate receptor 1 in human melanoma cells. Biochemical Pharmacology. 98: 182-9 |
DiRaddo JO, Miller EJ, Bowman-Dalley C, et al. (2015) Chloride is an Agonist of Group II and III Metabotropic Glutamate Receptors. Molecular Pharmacology. 88: 450-9 |
Hathaway HA, Pshenichkin S, Grajkowska E, et al. (2015) Pharmacological characterization of mGlu1 receptors in cerebellar granule cells reveals biased agonism. Neuropharmacology. 93: 199-208 |
Gelb T, Pshenichkin S, Rodriguez OC, et al. (2015) Metabotropic glutamate receptor 1 acts as a dependence receptor creating a requirement for glutamate to sustain the viability and growth of human melanomas. Oncogene. 34: 2711-20 |
Gelb T, Pshenichkin S, Hathaway HA, et al. (2015) Abstract A15: mGlu1 Receptors and downstream signal transduction proteins as therapeutic targets for the treatment of metastatic melanoma Cancer Research. 75 |
Gelb T, Hathaway HA, Wroblewski JT. (2014) Triple threat treatment: Exploiting the dependence receptor properties of metabotropic glutamate receptor 1 against melanoma. Molecular & Cellular Oncology. 1: e969163 |
DiRaddo JO, Miller EJ, Hathaway HA, et al. (2014) A real-time method for measuring cAMP production modulated by Gαi/o-coupled metabotropic glutamate receptors. The Journal of Pharmacology and Experimental Therapeutics. 349: 373-82 |
DiRaddo JO, Pshenichkin S, Gelb T, et al. (2013) Two newly identified exons in human GRM1 express a novel splice variant of metabotropic glutamate 1 receptor. Gene. 519: 367-73 |
Emery AC, DiRaddo JO, Miller E, et al. (2012) Ligand bias at metabotropic glutamate 1a receptors: molecular determinants that distinguish β-arrestin-mediated from G protein-mediated signaling. Molecular Pharmacology. 82: 291-301 |